Search
for

    Sort by

    Research 871–900 of 1000+

    1. A Comprehensive Review on Alopecia Areata and its Pathophysiology, Diagnosis, Treatment, and Psychosocial Impact Zenodo (CERN European Organization for Nuclear Research) · 2026
    2. Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications Journal of the European Academy of Dermatology and Venereology · 2025
    3. ‘Ritlecitinib: unveiling hair regrowth for alopecia areata’ Annals of Medicine and Surgery · 2024
    4. A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System Military medicine · 2024
    5. The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes 2024
    6. Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms” International journal of impotence research · 2024
    7. Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata The Open Dermatology Journal · 2023
    8. Overview of alopecia areata for managed care and payer stakeholders in the United States Journal of managed care & specialty pharmacy · 2023
    9. The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata Hair transplant forum international · 2022
    10. The Growing Role for Platelet Rich Plasma in Cosmetic Dermatology Cosmetic Dermatology · 2022
    11. Sunscreen: Cosmetic or medical therapy? Journal of The American Academy of Dermatology · 2018
    12. Laser for Hair Removal Springer eBooks · 2018
    13. Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men Annals of Internal Medicine · 2014
    14. Efeitos da finasterida sobre culturas de células epiteliais prostáticas normais e tumorais em diferentes sistemas in vitro Americanae (AECID Library) · 2013
    15. View Point- Synthetic hairs: Should they be used? Belarusian State Pedagogical University repository (Belarusian State Pedagogical University) · 2006
    16. Progress in the Application of Exosomes in Androgenetic Alopecia: Focusing on Molecular Mechanisms International Journal of Nanomedicine · 2026
    17. Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil Zenodo (CERN European Organization for Nuclear Research) · 2026
    18. Machine Learning–Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated with Minoxidil Zenodo (CERN European Organization for Nuclear Research) · 2026
    19. 76596 Nutraceuticals and Foods as Adjunctive Treatment for Androgenetic Alopecia (AGA): A Systematic Review Journal of the American Academy of Dermatology · 2026
    20. 73143 Stem Cell Therapies for Androgenetic Alopecia: A Systematic Review and Single-Arm Meta-analysis Journal of the American Academy of Dermatology · 2026
    21. 化療掉髮:頭皮冷凍帽(scalp cooling)真的有效嗎? Open MIND · 2026
    22. Rethinking serotonin’s role in mental health C&EN Global Enterprise · 2026
    23. Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology Dermatological Reviews · 2026
    24. Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis JMIR Dermatology · 2026
    25. Literature Review International Society of Hair Restoration Surgery · 2026
    26. Machine Learning--Enhanced Pharmacovigilance Assessment of Cardiac Adverse Events Associated With Minoxidil 2026
    27. Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System Journal of Dermatological Treatment · 2026
    28. 62335 Low Dose Oral Minoxidil vs Topical Minoxidil for Androgenetic Alopecia: Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal of the American Academy of Dermatology · 2025
    29. Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis SSP Modern Pharmacy and Medicine · 2025
    30. Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system The Journal of Sexual Medicine · 2025